binding site

(redirected from Binding sites)
Also found in: Medical.

binding site

[′bīn·diŋ ‚sīt]
(chemistry)
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Conclusion: Lower plants extracts were reported to exhibit better interactions with the taxol and epothilone binding sites. Whereas marine and higher plants isolates shows significant interactions only in the wild type instead of the mutants.
In order to analyze the ligand binding site of BACE1 and BACE2, only chain A of both 3D structures was selected, and amino acid residues within 5 [Angstrom] distance from the ligand were defined as ligand binding sites.
Harris said that for some time there has been suggestive evidence that these ion channels are important binding sites for alcohol.
Recent studies have yielded confounding results concerning the number of cocaine binding sites and whether it inhibits DA binding to DAT in a competitive or non-competitive manner.
If choline is added to a culture of pneumococci, the molecules occupy the choline binding sites of the CBPs so that the proteins no longer can bind to the cell walls of the pneumococci.
Currently, the stoichiometry of iron to frataxin is unknown, as is the exact iron binding sites. Surrogate metals are used to study iron binding to frataxin because Fe(II) is quickly oxidized to Fe(III) when exposed to oxygen.
In order to enhance knowledge on possible binding sites of mistletoe lectins, we examined interaction of ML I with an arabinogalactan-protein (AGP) from Echinacea purpurea.
In addition, the THF-diols are apparently devoid of estrogenic activity and do not bind to the estrogen receptor (ER) or nuclear type II [[sup.3]H]estradiol binding sites (Markaverich et al.
The C8a subunit contains distinct binding sites for C8b, C8g, C9, and the complement regulatory protein CD59.
The patent, issued on December 25, 2001 by the United States Patent and Trademark Office, covers a method to use NMR to elucidate the structure of the binding sites of biligand enzymes, which comprise approximately one-sixth of all human enzymes and are the targets for a number of currently available drugs.
The number of active binding sites of covalently coupled Mab 5A10 or Mab H50 on a single nanoparticle-antibody bioconjugate was determined using terbium(III)-labeled PSA, measuring the ratio between terbium(III) fluorescence from particle-bound labeled PSA and europium(III) fluorescence from nanoparticles (17).